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Magnetic resonance imaging (MRI) is widely used 
in diagnostics of malignant tumors and evaluation 
of anticancer treatment efficacy bough in human and 
experimental models. T2- and T1-weighted images 
are routinely applied, providing information about size 
and internal structure of tumor, its relationship with sur-
rounding tissues, the presence and severi ty of contrast 
enhancement. In addition to these anatomical MRI 
techniques, so called “functional” sequences has been 
developed in recent years. In functional MRI unique 
pathophysiological features of tissues are used for 
creation of images such as blood flow changes (ische-
mia, angiogenesis) in perfusion MRI and changes 
in the cellular composition (hypercellularity, necrosis) 
in diffusion-weighted MRI (DWI).
Initially DWI has been applied for early diagnos-
tics of brain ischemia [1]. Cytotoxic edema develops 
immediately after blood flow shut down in the af-
fected region of the brain. It characterized by fluid 
flow into intracellular space followed by cells swelling 
and decreasing of free mobility of water molecules 
in the constricted extracellular space. These areas 
with decreased water diffusion have altered signal 
on diffusion-weighted images, allowing to identify 
ischemia several hours earlier than on T2-weighted 
images. In recent years, it has been found that solid 
tumors are also characterized by decreased diffusion 
as they usually have increased cellular density. In op-
posite, areas of necrosis have increased diffusion due 
to absence of cell membranes as barriers for mobility 
of water molecules [2].
DWI has been used to detect tumors [3], to dif-
ferentiate benign from malignant tumor types [4], 
and to detect diffusion changes after tumor therapy 
in human [5] and animal models [2, 6]. For assess-
ment of antiangiogenic drugs therapies, DWI offers an 
attractive alternative to anatomic size measurements 
and/or histopathology because changes in size may 
not correlate with therapeutic efficacy, size changes 
may occur with significant delay relative to functional 
changes in tumor physiology and the invasive nat ure 
of histopathology complicates longitudinal studies. An 
important advantage of DWI is the possibility of quanti-
tative assessment by constructing map of the apparent 
diffusion coefficient (ADC map). In the present work we 
demonstrate use of DWI for non-invasive assessment 
of tumor internal structure changes in experimental 
model of peritoneal carcinomatosis treated with anti-
angiogenic drug Avastin with morphologic correlation.
Tumor model. Animal experiments were conducted 
in compliance with all ethical and legal requirements. 
An experimental animal, a white rat, was obtained from 
the vivarium of the N.N. Alexandrov National Cancer 
Center of Belarus. M-1 sarcoma, a transplantable rat 
tumor, was used in the experiments. The strain was 
obtained from the Oncology Research Centre of the 
Russian  Academy of Medical Sciences and was passed 
by serial transplantation. Tumor nodes were isolated 
and homogenized, then Hank’s solution was added to 
yield 10% suspension. The tumor cell suspension was 
injected under the capsule of the peritoneal surface 
in the left lower side of the abdomen.
MRI scanning and treatment. Baseline MRI scan 
was performed under general anesthesia 19 days 
after tumor transplantation and consisted of coronal 
and transversal T2- and T1-weighted images followed 
by DWI in transversal plane. Positions and thickness 
(3 mm) of DWI slices were copied from transversal 
T2-weighted images which served as anatomic refe-
rence. Four central tumor slices were underwent future 
quantitative analysis in correlation with histology.
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Immediately after MRI Bevacizumab (Avastin) 
endothelial growth factor antibody (Genentech Inc., 
South San Francisco, CA) was injected in tail vein in 
dose 15 mg/kg. Animal was undergone to MRI for 
noninvasive monitoring at 24, 48, 80 and 100 h after 
single dose Avastin injection using the same scanning 
protocol as described above.
Morphology examination. To validate the data of 
MRI animal was sacrificed after last MRI examination 
(according to the regulations of local Ethic Committee). 
At necropsy, the tumor was removed and fixed in 10% 
neutral buffered formalin for over 24 h. Four transversal 
parallel 3 mm thick sections were obtained through 
center of the tumor in correspondence to transversal 
DWI and T2-weighted images of MRI. H&E staining was 
done using standard protocols of histology investigation. 
Regions of necrosis were demarcated on the digital photo 
of the histology sections and percentage of necrotic 
tumor area was calculated for each section.
ADC maps analysis. ADC maps were recon-
structed from DWI series using scanner software. 
Diffusion-weighted images and ADC maps have lower 
spatial resolution and, thus, are interpreted together 
with Т2- and Т1-weighted images, which serve as 
anatomic reference. On the ADC map signal intensity 
of each pixel corresponds to the diffusion coefficient 
at this point. Necrotic areas which are characterized 
by increased diffusion have increased signal (appears 
white) while solid tumor parts look dark. To analyze ADC 
maps quantitatively ImageJ program (NIH, Bethesda, 
USA) was used. Tumor node was contoured and ADC 
threshold was found for which the total area of pixels 
in each slice with the intensity of the signal above the 
threshold value (ADC-derived tumor necrotic area) 
best suited to the area of necrosis in corresponding 
morphology slice (histology-derived tumor necrotic 
area). Sum of square differences (SSD) technique 
was used to find an optimal threshold [7]. The optimal 
threshold value was determined as that which yield the 
minimum SSD between ADC- and histology-derived 
tumor necrotic areas on four analyzed tumor slices. As 
shown in Fig. 1 minimum SSD was obtained with ADC 
threshold of 1.39 × 10–3 mm2/s. Fig. 2 shows correlation 
plots of ADC- and histology-derived tumor necrotic 
areas estimated using representative ADC thresholds 
of 1.35, 1.39 and 1.41 × 10–3 mm2/s relative to the model 
x = y line. Threshold of 1.35 × 10–3 mm2/s overestimates 
tumor necrosis compared to histology while threshold 
of 1.41 × 10–3 mm2/s underestimates it. Using optimal 
ADC threshold of 1.39 × 10–3 mm2/s, percentage of 
ADC-derived tumor necrotic area on each of four 
slices was 21.1, 16.4, 15.7 and 28.8%, showing excel-
lent correspondence to 21.1, 18.6, 15.9 and 28.6% on 
histology respectively. MRI and pathology images from 
representative tumor slice are shown on Fig. 3.
ADC maps analysis allowed to follow temporal 
changes of tumor internal structure after treatment. 
ADC-derived tumor necrotic volume increased gradu-
ally from 6.7% before treatment to 11.6% at 48 h and 
up to 27.7% at 80 h after Avastin injection.
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Fig. 1. Plot of sum of square differences (SSD) of ADC- and 
histology-derived tumor necrotic areas on four slices versus ADC 
threshold. Minimal SSD value was achieved with ADC threshold of 
1.39 × 10–3 mm2/s indicating best correspondence of ADC- and 
histology derived tumor necrotic areas
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Fig. 2. Correlation plots between ADC- and histology-derived tumor 
necrotic areas relative to the model x = y line. Every point on the plot 
corresponds to individual tumor slice. Representative ADC thre-
sholds of (a) 1.35, (b) 1.39 and (c) 1.41 × 10–3 mm2/s are shown. The 
best correspondence of ADC-derived and histology-derived tumor 
necrotic areas is achieved with ADC threshold of 1.39 × 10–3 mm2/s
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In conclusion, DWI uses local water mobility as 
an endogenous probe for noninvasive interrogation 
of tissue microstructure and may permit tissue cha-
racterization without the need for exogenous contrast 
agents. It offers non-invasive evaluation of tumor 
necrotic fraction before, during and after treatment 
and, therefore, may be used to individualise therapy 
and to monitor tumor response.
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Fig. 3. MRI (a–c) and histology (d) images from representative slice of M1-sarcoma at 100 h post treatment with Avastin: (a) T2-weighted 
image and (b) ADC map of the experimental animal whole body transversal cross-section; (c) ADC map and (d) H&E stained section 
of evaluated tumor node which is delineated on (b). Red pixels on (c) represent ADC values above 1.39 × 10–3 mm2/s threshold which 
appeared optimal for discrimination of solid and necrotic areas on this tumor model. White areas in the tumor on (b) and red pixels 
on (c) excellently match necrotic areas in the H&E stained section (arrows on (d)) as opposed to T2-weigted image on which tumor 
necrosis is not easily appreciated
